These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3259931)

  • 21. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.
    Morelli M; Fenu S; Garau L; Di Chiara G
    Eur J Pharmacol; 1989 Mar; 162(2):329-35. PubMed ID: 2566500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.
    Mattingly BA; Rowlett JK; Lovell G
    Psychopharmacology (Berl); 1993; 110(3):320-6. PubMed ID: 7831425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist.
    White FJ
    Eur J Pharmacol; 1987 Mar; 135(1):101-5. PubMed ID: 3494620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.
    Dall'Olio R; Gandolfi O; Vaccheri A; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1988; 95(3):381-5. PubMed ID: 2901128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L; Longoni R; Mulas A; Di Chiara G
    Psychopharmacology (Berl); 1989; 98(4):567-8. PubMed ID: 2570436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors.
    Criswell HE; Mueller RA; Breese GA
    Eur J Pharmacol; 1989 Jan; 159(2):141-7. PubMed ID: 2495973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors.
    Starr MS
    Eur J Pharmacol; 1988 Jul; 151(3):479-82. PubMed ID: 3265106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1987 Sep; 141(1):101-7. PubMed ID: 3117576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S; Cabib S
    Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M; Danek L; Smiałowski A
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of selective dopamine receptor agonists and antagonists on body temperature in rats.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1987 Jan; 133(3):243-7. PubMed ID: 2951265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.